肝硬化门静脉高压症的治疗对腹部外科学仍是一个挑战。目前的手术方式主要有分流和断流术 ,然而肝硬化患者肝储备功能往往不足以耐受手术及麻醉的打击 ,因而手术病死率较高。随着内镜、影像技术的发展及新材料、新设备的出现 ,微创治疗以其创伤小、适应证广、疗效显著而成为当代研究的重点。该文作者对目前肝硬化门静脉高压症的微创治疗现状和进展作一综述 The treatment of cirrhosis and portal hypertension is still a challenge for abdominal surgery. The current surgical methods are mainly shunt and flow, but patients with liver cirrhosis are often not enough to reserve the liver function to withstand surgery and anesthesia hit, so the higher operative mortality. With the development of endoscopy and imaging technology and the emergence of new materials and new equipment, minimally invasive treatment has become the focus of contemporary research with its small trauma, widely used indications and remarkable curative effect. The author reviews the current status and progress of minimally invasive treatment of cirrhotic portal hypertension